- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is seeking an individual with significant research experience to lead a program addressing clinical research and intervention in diabetes and endocrine disorders in the Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD). The DDEMD supports and provides leadership for research on the causes, prevention and
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is seeking an individual with significant research experience to lead a program addressing clinical research and intervention in diabetes and endocrine disorders in the Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD). The DDEMD supports and provides leadership for research on the causes, prevention and
The COVID-19 pandemic continues to present considerable public health challenges in the United States and around the globe. One of the most puzzling is why many people who get over an initial and often relatively mild COVID illness later develop new and potentially debilitating symptoms. These symptoms run the gamut including fatigue, shortness of breath, brain fog, anxiety, and gastrointestinal
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept — drugs widely used to treat certain autoimmune diseases — did not significantly shorten time to recovery but did substantially improve clinical status and reduce deaths. Some COVID-19 patients experience an immune
Wednesday, February 9, 2022, 12:00 PM - 1:00 PM NIEHS Virtual Security: Measures for Visitors to NIEHS Event Type: Virtual Event Contact: Voelker, Kerri: kerri.voelker@nih.gov, 919-794-4710 Principal Speaker: Robert D. Bullard, Ph.D., Texas Southern University Speaker Title: Distinguished Professor of Urban Planning and Environmental Policy Link: https://calendar.niehs.nih.gov/MasterCal_Public
The NEPTUNE Career Development program is designed to support advanced post-doctoral and junior faculty trainees, or established investigators interested in redirecting their investigative focus, who are preparing to become independent investigators in clinical and translational research in human glomerular disease.
Pilot Grant Program for Myasthenia Gravis
Objectives: MGNet, a NIH-funded Rare Diseases Clinical Research Consortium (RDCRC) in partnership with the Myasthenia Gravis Foundation of America and Conquer MG, is seeking proposals for highly innovative investigations in early stages of development. The priorities of the Pilot Grant Program are:
This RCCN Virtual Workshop will include sessions on aspects of including older adults in clinical research including the Current Situation, Barriers - Real and Perceived, Making the Case, and Best Practices Reaching for Out to Colleagues. View the draft agenda for the workshop here. This workshop will be held as a webinar, and registration is free and open to the public. Please register using this
NIMHD will host Dr. L. Ebony Boulware as the next NIMHD Director’s Seminar Series titled “Where Clouds Meet the Ground: Democratizing Health Data to Address Community Health Equity.” Dr. Boulware is the Eleanor Easley Chair at the School of Medicine and the chief of the Division of General Internal Medicine at the Department of Medicine at Duke University. As a general internist and clinical
Vasculitis refers to a group of rare diseases that involve inflammation of blood vessels, which disrupts blood flow and often causes damage to the body’s organs. The cause of most forms of vasculitis remains unknown, and treatments involve the use of strong medications that can have serious side effects. The Vasculitis Clinical Research Consortium (VCRC) is an international, multicenter clinical
The Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) focuses on several inherited and acquired disorders that cause thickened, infected secretions to accumulate in the upper and lower airways. Its work is conducted at eight clinical research sites across the United States and Canada. During the past 15 years, the consortium has made numerous advances that profoundly changed clinical
Eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis are disorders in which a type of immune cell (called eosinophils) builds up in the digestive tract, causing gastrointestinal tissue damage. These disorders are painful, lifelong, and make it hard or impossible for people to eat many or all foods. The Consortium of Eosinophilic Gastrointestinal